Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old
Clinical trial NCT01916252 · COMPLETED
Trial details
- NCT number
- NCT01916252
- Sponsor
- PETHEMA Foundation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2016-11-16
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.